Illumina Introduces Device to Lower Genome Analysis Costs

Medical Devices Directory Forums Product & Service Illumina Introduces Device to Lower Genome Analysis Costs

This topic contains 0 replies, has 1 voice, and was last updated by  Brückenkopf GmbH 10 months, 2 weeks ago.

Viewing 1 post (of 1 total)
  • Author
    Posts
  • #2064 Reply

    Illumina introduced the NovaSeqTM Series, a new and scalable sequencing architecture expected one day to enable a $100 genome. Unveiled at the J.P. Morgan Healthcare Conference, this platform redefines high throughput sequencing with unrivaled throughput, ease of use, low per sample costs, and unmatched flexibility.
    “The introduction of NovaSeq marks one of the most important inflection points of innovation in Illumina’s history. In the same way that HiSeq X enabled the $1,000 genome with the HiSeq® architecture first announced in 2010, we believe that future systems derived from the NovaSeq architecture we are launching today one day will enable the $100 genome and propel discoveries that will enable a deeper understanding and better treatments for complex disease,” said Francis deSouza, President and CEO of Illumina. “The NovaSeq Systems enable the study of genetic links between health and disease at an unprecedented scale by making it possible to sequence more samples at greater depth and take on projects that would otherwise be cost-prohibitive. By accelerating the trajectory of genomics with these systems, Illumina is making it possible to envision a future in which all people can benefit from precision medicine.”
    Source: Illumina

    Share
Viewing 1 post (of 1 total)
Reply To: Illumina Introduces Device to Lower Genome Analysis Costs
Your information:




Share